Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IRDM | Common Stock | Options Exercise | $1.09M | +179K | +26.67% | $6.08* | 849K | Aug 5, 2022 | Direct | |
transaction | IRDM | Common Stock | Sale | -$4.22M | -92.9K | -10.95% | $45.38 | 756K | Aug 5, 2022 | Direct | F1, F2 |
transaction | IRDM | Common Stock | Sale | -$78.1K | -1.72K | -0.23% | $45.35 | 754K | Aug 8, 2022 | Direct | F1, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IRDM | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -179K | -100% | $0.00* | 0 | Aug 5, 2022 | Common Stock | 179K | $6.08 | Direct | F4 |
Id | Content |
---|---|
F1 | These sales were for the sole purpose of paying the exercise price of the option reported on Table II of this form and the associated tax withholding obligations. |
F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.165 to $45.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this form Form 4. |
F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.345 to $45.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this form Form 4. |
F4 | The options vested and became exercisable as to 25% of the shares on March 1, 2014 and quarterly thereafter in equal installments on June 1, September 1 and December 1 so that all shares of common stock underlying the option vested and became exercisable on March 1, 2017. |